Sean Gaffney Sells 442 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Sean Gaffney sold 442 shares of the firm’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $46,569.12. Following the completion of the sale, the executive vice president owned 20,080 shares in the company, valued at approximately $2,115,628.80. The trade was a 2.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Sean Gaffney also recently made the following trade(s):

• On Tuesday, February 24th, Sean Gaffney sold 817 shares of Addus HomeCare stock. The shares were sold at an average price of $106.98, for a total transaction of $87,402.66.

Addus HomeCare Stock Performance

Addus HomeCare stock traded down $3.58 during mid-day trading on Thursday, reaching $104.02. The company had a trading volume of 269,378 shares, compared to its average volume of 239,147. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 1.26 and a beta of 0.91. The company has a 50 day moving average of $109.57 and a 200-day moving average of $113.08. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $124.43.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ADUS. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a report on Wednesday. BMO Capital Markets initiated coverage on Addus HomeCare in a research report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 target price for the company. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Monday. Finally, Barclays reduced their price objective on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $134.33.

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently made changes to their positions in the company. TimesSquare Capital Management LLC increased its position in shares of Addus HomeCare by 6.2% during the 3rd quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock worth $49,361,000 after purchasing an additional 24,301 shares in the last quarter. Russell Investments Group Ltd. grew its stake in Addus HomeCare by 10.1% during the second quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock worth $6,439,000 after buying an additional 5,110 shares during the last quarter. Public Sector Pension Investment Board grew its stake in Addus HomeCare by 14.4% during the third quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock worth $8,357,000 after buying an additional 8,893 shares during the last quarter. Creative Planning increased its holdings in shares of Addus HomeCare by 150.9% during the second quarter. Creative Planning now owns 7,024 shares of the company’s stock worth $809,000 after buying an additional 4,224 shares in the last quarter. Finally, Tributary Capital Management LLC raised its stake in shares of Addus HomeCare by 114.1% in the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after acquiring an additional 212,192 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.